?>
Logo

ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING 401k Plan overview

Plan NameALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING
Plan identification number 002

ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Participant-directed brokerage accounts provided as an investment option under the plan.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Non-U.S. plan - Pension plan maintained outside the United States primarily for nonresident aliens.
  • Plan covering Self-Employed individuals.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

ALLERGY & CLINICAL IMMUNOLOGY ASSOCIATES, PC has sponsored the creation of one or more 401k plans.

Company Name:ALLERGY & CLINICAL IMMUNOLOGY ASSOCIATES, PC
Employer identification number (EIN):251806736
NAIC Classification:621111
NAIC Description:Offices of Physicians (except Mental Health Specialists)

Form 5500 Filing Information

Submission information for form 5500 for 401k plan ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0022022-01-01JAMES N. DEANGELO DO2023-10-10
0022021-01-01JAMES N. DEANGELO DO2022-09-22
0022020-01-01JAMES N. DEANGELO DO2021-06-01
0022019-01-01JAMES N. DEANGELO DO2020-10-12
0022018-01-01RONALD A LANDAY MD2019-09-30
0022017-01-01RONALD A LANDAY MD2018-10-05
0022016-01-01RONALD A LANDAY MD2017-09-26
0022015-01-01RONALD A LANDAY MD2016-09-30
0022014-01-01RONALD A LANDAY MD2015-10-07
0022013-01-01RONALD A LANDAY MD2014-10-15
0022012-01-01RONALD A LANDAY MD2013-10-14
0022011-01-01RONALD A LANDAY MD
0022010-01-01RONALD A LANDAY MD
0022009-01-01RONALD A LANDAY MD
0022009-01-01RONALD A LANDAY MD

Plan Statistics for ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING

401k plan membership statisitcs for ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING

Measure Date Value
2011: ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING 2011 401k membership
Total participants, beginning-of-year2011-01-0127
Total number of active participants reported on line 7a of the Form 55002011-01-0128
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-010
Total of all active and inactive participants2011-01-0128
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-010
Total participants2011-01-0128
Number of participants with account balances2011-01-0129
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-010
2010: ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING 2010 401k membership
Total participants, beginning-of-year2010-01-0128
Total number of active participants reported on line 7a of the Form 55002010-01-0127
Number of retired or separated participants receiving benefits2010-01-010
Number of other retired or separated participants entitled to future benefits2010-01-010
Total of all active and inactive participants2010-01-0127
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2010-01-010
Total participants2010-01-0127
Number of participants with account balances2010-01-0130
2009: ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING 2009 401k membership
Total participants, beginning-of-year2009-01-0129
Total number of active participants reported on line 7a of the Form 55002009-01-0128
Total of all active and inactive participants2009-01-0128
Total participants2009-01-0128
Number of participants with account balances2009-01-0129

Financial Data on ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING

Measure Date Value
2011 : ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING 2011 401k financial data
Total plan liabilities at end of year2011-12-31$100
Total plan liabilities at beginning of year2011-12-31$100
Total income from all sources2011-12-31$89,434
Expenses. Total of all expenses incurred2011-12-31$98,789
Benefits paid (including direct rollovers)2011-12-31$98,468
Total plan assets at end of year2011-12-31$2,734,377
Total plan assets at beginning of year2011-12-31$2,743,732
Value of fidelity bond covering the plan2011-12-31$300,000
Expenses. Other expenses not covered elsewhere2011-12-31$42
Other income received2011-12-31$-27,846
Net income (gross income less expenses)2011-12-31$-9,355
Net plan assets at end of year (total assets less liabilities)2011-12-31$2,734,277
Net plan assets at beginning of year (total assets less liabilities)2011-12-31$2,743,632
Assets. Value of employer securities2011-12-31$100
Total contributions received or receivable from employer(s)2011-12-31$117,280
Expenses. Administrative service providers (salaries,fees and commissions)2011-12-31$279
2010 : ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING 2010 401k financial data
Total plan liabilities at end of year2010-12-31$100
Total plan liabilities at beginning of year2010-12-31$100
Total income from all sources2010-12-31$337,040
Expenses. Total of all expenses incurred2010-12-31$19,791
Benefits paid (including direct rollovers)2010-12-31$19,731
Total plan assets at end of year2010-12-31$2,743,632
Total plan assets at beginning of year2010-12-31$2,426,383
Value of fidelity bond covering the plan2010-12-31$300,000
Expenses. Other expenses not covered elsewhere2010-12-31$7
Other income received2010-12-31$226,172
Net income (gross income less expenses)2010-12-31$317,249
Net plan assets at end of year (total assets less liabilities)2010-12-31$2,743,532
Net plan assets at beginning of year (total assets less liabilities)2010-12-31$2,426,283
Total contributions received or receivable from employer(s)2010-12-31$110,868
Expenses. Administrative service providers (salaries,fees and commissions)2010-12-31$53

Form 5500 Responses for ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING

2011: ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement - TrustYes
2010: ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING 2010 form 5500 responses
2010-01-01Type of plan entitySingle employer plan
2010-01-01Submission has been amendedYes
2010-01-01Plan funding arrangement – TrustYes
2010-01-01Plan benefit arrangement - TrustYes
2009: ALLERGY & CLINICAL IMMUNOLOGY AMENDED & RESTATED PROFIT SHARING 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedYes
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement - TrustYes

Potentially related plans

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S3